Trials / Completed
CompletedNCT01181167
A Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty
A Phase 3, Randomized, Double-Blind, Double-Dummy Efficacy and Safety Study of the Oral Factor Xa Inhibitor DU-176b Compared With Enoxaparin Sodium for Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty (STARS J-5 Trial)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 610 (actual)
- Sponsor
- Daiichi Sankyo Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years – 84 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to assess the efficacy and safety of DU-176b compared with enoxaparin sodium for the prevention of venous thromboembolism in patients after elective total hip arthroplasty.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | edoxaban | |
| DRUG | enoxaparin sodium |
Timeline
- Start date
- 2009-05-01
- Primary completion
- 2010-01-01
- Completion
- 2010-03-01
- First posted
- 2010-08-13
- Last updated
- 2019-03-05
- Results posted
- 2015-01-26
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01181167. Inclusion in this directory is not an endorsement.